WILMINGTON, Del., May 14, 2012 /PRNewswire/ -- Synchrogenix Information Strategies Inc., a regulatory writing company headquartered in Wilmington, Delaware, is pleased to announce the addition of a new office in Stockholm, Sweden, to be headed by Bengt Olsson.
Synchrogenix CEO, Ellen Barrosse, has appointed Bengt Olsson as a Principal Regulatory Writer who will pilot the company’s newest office, located in Stockholm, Sweden. With more than 30 years of experience in managing, researching, and writing in the pharmaceutical industry, Mr. Olsson brings great strength to the Synchrogenix team. His background as a Research and Clinical Psychologist, matched with his strong record as a leader of international teams, makes him a great asset for SynchroSweden AB.
The opening of SynchroSweden AB marks Synchrogenix’s seventh major expansion in the past five years. In 2011, Synchrogenix opened offices in Austin, Texas, and San Diego, California (SynchroWest, Inc.); and expanded its offices in Malvern, Pennsylvania, and the United Kingdom (Synchrogenix Europe, Ltd.) to larger facilities. In 2010, Synchrogenix opened an office in Cambridge, Massachusetts. The Synchrogenix office in Manila, Philippines (Synchrogenix Philippines, Inc.) opened in 2008.
The Synchrogenix Group encompasses a group of separate entities operating together to provide regulatory writing services to the pharmaceutical, biotech, and medical device industries worldwide. Synchrogenix Information Strategies Inc.; SynchroWest, Inc.; Synchrogenix Europe, Ltd.; SynchroSweden AB; and Synchrogenix Philippines, Inc., are all privately held organizations with a shared board of directors and an overall governance structure that creates and enforces a global standard of service, technology, and quality.
SOURCE Synchrogenix Information Strategies Inc.
